Key Takeaways
- • Connecticut lawmakers are advancing Senate Bill 196 for the third consecutive year to restrict private equity ownership in hospitals, with the bill passing the Senate and moving to the House for a vote as of April 2026.
- • S.B. 196 would prohibit private equity investors from holding majority stakes in hospital main campus operations and ban their involvement in clinical decision-making, directly addressing fallout from three existing private equity-owned Connecticut hospitals.
- • The legislation explicitly blocks "sale-leaseback" transactions, a primary mechanism through which private equity generates returns by selling hospital buildings to real estate investment trusts while leaving hospitals obligated to pay rent on their own facilities.
- • Gov. Ned Lamont's office and the Public Health Committee co-chairs have been in "robust conversations" over recent months to align separate gubernatorial and legislative proposals, signaling renewed coordination after previous years' failures to pass complementary measures.
- • Previous regulatory attempts in 2024 and 2025 failed despite bipartisan support, with both the governor and legislature blaming each other; this year's aligned strategy aims to overcome past legislative gridlock before the session closes.
Summary
Connecticut legislators are making a third attempt to regulate private equity ownership in healthcare, with Senate Bill 196 passing the chamber on April 23, 2026, and advancing to the House for consideration. The proposal directly targets operational and financial structures that have generated investor returns while straining hospital finances across three Connecticut healthcare facilities currently under private equity control.
The legislation takes a two-pronged approach to restrict PE involvement. First, it prevents private equity investors from acquiring majority ownership stakes in hospital main campus operations and bars them from participating in clinical decision-making. This provision addresses concerns that PE ownership incentivizes cost-cutting measures that may compromise patient care and medical autonomy. Second, S.B. 196 explicitly prohibits sale-leaseback transactions, a financial engineering tool where hospitals sell their physical campuses to real estate investment trusts, then lease the buildings back at market rates. While these deals generate immediate cash and investor returns, they leave hospitals as permanent tenants paying ongoing rent obligations on their own infrastructure—a financial burden that constrains operational investment and service expansion.
According to Public Health Committee co-chair Sen. Saud Anwar (D-South Windsor), the 2026 legislative push differs materially from failed attempts in prior years due to sustained coordination between the legislature and Governor Lamont's office. "We have been in robust conversations for the past two months," Anwar stated, signaling that separate proposals from the governor and lawmakers are now "meant to complement each other" rather than compete. In contrast, 2025 ended in legislative failure when both branches proposed divergent approaches but failed to reconcile them before the session concluded, with each side accusing the other of obstruction.
Governor Lamont's spokesperson Cathryn Vaulman did not explicitly endorse S.B. 196 but reiterated the governor's "commitment to reining in private equity," leaving open the possibility of alignment on details during the House consideration phase. With the Senate bill now advancing and demonstrated willingness from the executive branch to coordinate, institutional investors and PE-backed healthcare operators should monitor House proceedings closely, as passage would represent the first successful regulatory framework targeting PE healthcare ownership in Connecticut.
The legislation takes a two-pronged approach to restrict PE involvement. First, it prevents private equity investors from acquiring majority ownership stakes in hospital main campus operations and bars them from participating in clinical decision-making. This provision addresses concerns that PE ownership incentivizes cost-cutting measures that may compromise patient care and medical autonomy. Second, S.B. 196 explicitly prohibits sale-leaseback transactions, a financial engineering tool where hospitals sell their physical campuses to real estate investment trusts, then lease the buildings back at market rates. While these deals generate immediate cash and investor returns, they leave hospitals as permanent tenants paying ongoing rent obligations on their own infrastructure—a financial burden that constrains operational investment and service expansion.
According to Public Health Committee co-chair Sen. Saud Anwar (D-South Windsor), the 2026 legislative push differs materially from failed attempts in prior years due to sustained coordination between the legislature and Governor Lamont's office. "We have been in robust conversations for the past two months," Anwar stated, signaling that separate proposals from the governor and lawmakers are now "meant to complement each other" rather than compete. In contrast, 2025 ended in legislative failure when both branches proposed divergent approaches but failed to reconcile them before the session concluded, with each side accusing the other of obstruction.
Governor Lamont's spokesperson Cathryn Vaulman did not explicitly endorse S.B. 196 but reiterated the governor's "commitment to reining in private equity," leaving open the possibility of alignment on details during the House consideration phase. With the Senate bill now advancing and demonstrated willingness from the executive branch to coordinate, institutional investors and PE-backed healthcare operators should monitor House proceedings closely, as passage would represent the first successful regulatory framework targeting PE healthcare ownership in Connecticut.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.